Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.75
0.47%
After-hours: Aug 15, 2025, 04:10 PM EDT
Inhibikase Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -3.58 | -4.65 | -0.5 | -0.47 | -0.74 | -0.47 | -0.4 | -0.82 | -1.13 | -0.76 | -1.28 | -1.01 | -2.01 | -1.84 | -2.67 | -3.25 | -5.73 |
PEG Ratio | 0.05 | 0.22 | 0.33 | 0.05 | -0.1 | 0.02 | 0.02 | -0.03 | 0.09 | 0.11 | 0.35 | n/a | 0.24 | -0.15 | 0.16 | 0.18 | -0.07 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | 93.33 | 162.07 | 280.70 | 102.18 | n/a | 2.86K | 810.41 | 19.08K | 145.45 | 25.15 | 42.94 |
PB Ratio | 2.29 | 2.38 | -21.76 | 1.83 | 2.02 | 0.72 | 0.49 | 0.97 | 0.72 | 0.60 | 0.92 | 0.64 | 1.10 | 0.97 | 1.11 | 0.73 | 7.52 |
P/FCF Ratio | -47.78 | -42.17 | -2.37 | -1.85 | -3.54 | -2.29 | -1.81 | -4.12 | -3.03 | -3.76 | -4.04 | -4.26 | -9.48 | -9.06 | -23.64 | -8.07 | -15.36 |
P/OCF Ratio | -47.78 | -42.17 | -2.37 | -1.85 | -3.54 | -2.28 | -1.81 | -4.13 | -3.03 | -3.55 | -4.19 | -4.31 | -9.48 | -9.06 | -23.64 | -8.07 | -15.36 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | -51.59 | -39.22 | -92.56 | -28.81 | n/a | -664.8 | -85.47 | -2.11K | -6.15 | -3.12 | -2.8 |
Debt / Equity Ratio | 0.00 | 0.00 | -0.27 | 0.03 | 0.03 | 0.06 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | n/a | n/a | 0.01 | 0.01 | 0.01 | 0.15 |
Quick Ratio | 11.01 | 26.37 | 0.85 | 2.32 | 2.55 | 4.13 | 6.40 | 7.89 | 10.02 | 6.29 | 8.42 | 7.36 | 8.64 | 10.45 | 16.84 | 25.23 | 3.11 |
Current Ratio | 11.01 | 26.37 | 0.85 | 2.32 | 2.55 | 4.13 | 6.40 | 8.04 | 10.37 | 6.59 | 8.71 | 7.56 | 8.76 | 10.47 | 16.94 | 25.73 | 3.31 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.01 | 0.00 | 0.00 | n/a | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.12 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -928.12K | -31.91K | -28.48K | -336.5 | -222.54 |
Return on Equity | -0.16 | -0.13 | 10.89 | -0.97 | -0.69 | -0.38 | -0.31 | -0.3 | -0.16 | -0.2 | -0.18 | -0.16 | -0.14 | -0.13 | -0.1 | -0.06 | -0.33 |
Return on Assets | -0.15 | -0.12 | -1.32 | -0.56 | -0.42 | -0.29 | -0.26 | -0.26 | -0.14 | -0.17 | -0.16 | -0.14 | -0.12 | -0.12 | -0.1 | -0.05 | -0.22 |
Return on Invested Capital | -0.17 | -0.14 | 18.58 | -0.93 | -0.66 | -0.38 | -0.31 | -0.31 | -0.16 | -0.2 | -0.18 | -0.16 | -0.14 | -0.13 | -0.1 | -0.06 | -0.28 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | 0.92 | -0.37 | 0.92 | 0.96 | n/a | -454.16 | -64.54 | -1.74K | -8.6 | -0.75 | -0.73 |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -57.75 | -49.63 | -62.05 | -33.76 | n/a | -708.17 | -100.81 | -2.59K | -13.61 | -1.93 | -1.87 |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -57.75 | -49.63 | -69.4 | -34.67 | n/a | -708.17 | -100.81 | -2.59K | -13.61 | -1.93 | -1.87 |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -59.93 | -53.28 | -73.08 | -35.12 | n/a | -708.17 | -100.81 | -2.59K | -13.61 | -1.93 | -1.87 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | -59.85 | -51.91 | -73 | -35.08 | n/a | -708.17 | -100.81 | -2.59K | -13.61 | -1.93 | -1.87 |